Literature DB >> 9499422

Conserved use of a non-canonical 5' splice site (/GA) in alternative splicing by fibroblast growth factor receptors 1, 2 and 3.

S R Twigg1, H D Burns, M Oldridge, J K Heath, A O Wilkie.   

Abstract

The two classes of sequences for recognition and splicing of pre-mRNA in eukaryotes, GT-AG and AT-AC, are characterized by the nearly invariant dinucleotides present at the extreme 5' (donor) and 3' (acceptor) ends of the intron. Amongst GT-AG introns, which comprise the vast majority, the more extended consensus sequence at the 5' splice site isACAG/GTAGAGT (where / indicates the exon-intron boundary). This sequence is complementary to part of the U1 snRNA and is important in intron recognition. We have determined the genomic structure of the mouse fibroblast growth factor receptor 2 gene (Fgfr2) and identified a divergent 5' splice site (ACA/GAAAGT), conserved in FGFR1 , - 2 and - 3 from humans, mice and Xenopus that is used for alternative splicing of a hexanucleotide sequence, encoding Val-Thr, at the end of exon 10. This is the only example known of the use of /GA in vertebrate splicing. Similarities to a splice site in the Antennapedia gene of Drosophila suggest that this variant motif is involved in alternative splicing of short sequences at the 5' splice site. Inclusion or exclusion of the Val-Thr dipeptide may play an important role in controlling FGFR signalling through the Ras/MAPK pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9499422     DOI: 10.1093/hmg/7.4.685

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  14 in total

1.  Fgfr2 is required for limb outgrowth and lung-branching morphogenesis.

Authors:  E Arman; R Haffner-Krausz; M Gorivodsky; P Lonai
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  Efficient use of a 'dead-end' GA 5' splice site in the human fibroblast growth factor receptor genes.

Authors:  Simon Brackenridge; Andrew O M Wilkie; Gavin R Screaton
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

3.  Profiling of cis- and trans-acting factors supporting noncanonical splice site activation.

Authors:  Steffen Erkelenz; Gereon Poschmann; Johannes Ptok; Lisa Müller; Heiner Schaal
Journal:  RNA Biol       Date:  2020-08-05       Impact factor: 4.652

4.  De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome.

Authors:  M Oldridge; E H Zackai; D M McDonald-McGinn; S Iseki; G M Morriss-Kay; S R Twigg; D Johnson; S A Wall; W Jiang; C Theda; E W Jabs; A O Wilkie
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

5.  A new method for generating point mutations in bacterial artificial chromosomes by homologous recombination in Escherichia coli.

Authors:  M Lalioti; J Heath
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

Review 6.  2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology.

Authors:  Richard J Epstein; Li Jun Tian; Yan Fei Gu
Journal:  J Oncol       Date:  2021-04-30       Impact factor: 4.375

7.  A comprehensive survey of non-canonical splice sites in the human transcriptome.

Authors:  Guillermo E Parada; Roberto Munita; Cledi A Cerda; Katia Gysling
Journal:  Nucleic Acids Res       Date:  2014-08-14       Impact factor: 16.971

8.  Molecular Analysis of Twist1 and FGF Receptors in a Rabbit Model of Craniosynostosis: Likely Exclusion as the Loci of Origin.

Authors:  Phillip H Gallo; James J Cray; Emily L Durham; Mark P Mooney; Gregory M Cooper; Sandeep Kathju
Journal:  Int J Genomics       Date:  2013-05-08       Impact factor: 2.326

9.  Congenital hypogonadotropic hypogonadism with split hand/foot malformation: a clinical entity with a high frequency of FGFR1 mutations.

Authors:  Carine Villanueva; Elka Jacobson-Dickman; Cheng Xu; Sylvie Manouvrier; Andrew A Dwyer; Gerasimos P Sykiotis; Andrew Beenken; Yang Liu; Johanna Tommiska; Youli Hu; Dov Tiosano; Marion Gerard; Juliane Leger; Valérie Drouin-Garraud; Hervé Lefebvre; Michel Polak; Jean-Claude Carel; Franziska Phan-Hug; Michael Hauschild; Lacey Plummer; Jean-Pierre Rey; Taneli Raivio; Pierre Bouloux; Yisrael Sidis; Moosa Mohammadi; Nicolas de Roux; Nelly Pitteloud
Journal:  Genet Med       Date:  2014-11-13       Impact factor: 8.822

10.  Cutting a Long Intron Short: Recursive Splicing and Its Implications.

Authors:  Theodore Georgomanolis; Konstantinos Sofiadis; Argyris Papantonis
Journal:  Front Physiol       Date:  2016-11-29       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.